CervoMed Inc.CRVONASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank86
5Y CAGR+17.7%
Studio
Year-over-Year Change

Price-to-book ratio

5Y CAGR
+17.7%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20253.92+713.4%
20240.48-82.5%
20232.75+729.7%
2022-0.44-150.4%
20210.87-50.0%
20201.74+1032.7%
20190.15-62.9%
20180.41-40.3%
20170.69-72.5%
20162.52-